Skip to main content
Top
Published in: Comparative Clinical Pathology 5/2018

01-09-2018 | Original Article

Calculation of effective dose fifty (ED50) of antivenom for American pit viper envenomation

Author: Saganuwan Alhaji Saganuwan

Published in: Comparative Clinical Pathology | Issue 5/2018

Login to get access

Abstract

The use of conventional approved snake antivenom is the most reliable snake envenomotherapy at the moment. However, because of post-treatment hypersensitivity reactions sometimes caused by large doses of snake antivenoms, the treatment of snake poisoning needs to be reviewed. The effective dose fifty (ED50) of snake antivenom was calculated for 11 American pit viper envenomation as reported by Consroe et al. Four different ED50 formulas were used to determine effective dose fifty of snake antivenom against LD50 of the snake venoms using intravenous route. The findings revealed that snake envenomotherapy is in monotonic dose-response fashion with each formular producing ED50 value for specific snake. The difference in values may be due to species of snakes and the types of ED50 formula used. All the ED50 formulas with the LD50 as numerator yielded higher effective therapeutic dose of snake antivenoms and corresponding higher LD50 values of snake venoms. The lower the denominator, the lower the LD50 and the ED50 value, and the lower the chance of hypersensitivity reaction, but the higher may be the chance of the snake antivenom failure. Therefore, Saganuwan’s formula \( \left({\mathrm{LD}}_{50}=\frac{ED_{50}}{3}\ x\ Wa\ x\ {10}^{-4}\right) \), whereas Wa is weight of animal, could produce effective envenometherapy with low chance of hypersensitivity reactions.
Literature
go back to reference Abubakar IS (2010) Randomized controlled double-blind non-infirmity trial of two antivenins for saw-scaled or carpet viper (Eschris ocellatus) envenoms in Nigeria. Plos Negl Trop Dis 4:e767CrossRefPubMedPubMedCentral Abubakar IS (2010) Randomized controlled double-blind non-infirmity trial of two antivenins for saw-scaled or carpet viper (Eschris ocellatus) envenoms in Nigeria. Plos Negl Trop Dis 4:e767CrossRefPubMedPubMedCentral
go back to reference Aguilar I, Sanches EE, Giron ME, Estrella A, Guerrero B, Rodriquez- Acosta FL (2014) Coral snake antivenom produced in chickens (Gallus domesticus). Rev Inst Med Trop Sao Paulo 56(1):61–66CrossRefPubMedPubMedCentral Aguilar I, Sanches EE, Giron ME, Estrella A, Guerrero B, Rodriquez- Acosta FL (2014) Coral snake antivenom produced in chickens (Gallus domesticus). Rev Inst Med Trop Sao Paulo 56(1):61–66CrossRefPubMedPubMedCentral
go back to reference Allen GE, Brown GA, Buckley NA (2012) Clinical effects and antivenom dosing in brown snake (pseudonaja spp.) envenoming—Australian snakebite project (ASP-14). Plos One 7(12):1CrossRef Allen GE, Brown GA, Buckley NA (2012) Clinical effects and antivenom dosing in brown snake (pseudonaja spp.) envenoming—Australian snakebite project (ASP-14). Plos One 7(12):1CrossRef
go back to reference Bieber AL (1979) Metal and non-protein constituents in snake venom. In: Lee Y (ed) Snake venoms: handwork of experimental pharmacology. Springer Verlag, Berlin, pp 295–3006CrossRef Bieber AL (1979) Metal and non-protein constituents in snake venom. In: Lee Y (ed) Snake venoms: handwork of experimental pharmacology. Springer Verlag, Berlin, pp 295–3006CrossRef
go back to reference Birrell GW, Isbister GK, Masci PP, de Jersey J, Wallis TP (2006) Molecular diversity in venom from the Australian brown snake, Pseudonaja textilis. Mol Cell Proteomics 5:379–389CrossRefPubMed Birrell GW, Isbister GK, Masci PP, de Jersey J, Wallis TP (2006) Molecular diversity in venom from the Australian brown snake, Pseudonaja textilis. Mol Cell Proteomics 5:379–389CrossRefPubMed
go back to reference Cham G, Lim F, Earnest A, Gopalakrishnakone (2013) Cross–reactivity against Naja sumatrana (black spitting cobra) envenoming from the Haffkine antivenom in a mouse model. ISRN Toxicol 247645:1–6CrossRef Cham G, Lim F, Earnest A, Gopalakrishnakone (2013) Cross–reactivity against Naja sumatrana (black spitting cobra) envenoming from the Haffkine antivenom in a mouse model. ISRN Toxicol 247645:1–6CrossRef
go back to reference Chippaux JP, Goyfton M (1983) Producers of antivenom sera. Toxin 21:739–752 Chippaux JP, Goyfton M (1983) Producers of antivenom sera. Toxin 21:739–752
go back to reference Chippaux JP, Williams V, White J (1991) Snake venom variability methods of study results and interpretation. Toxicon 29:1279–1303CrossRefPubMed Chippaux JP, Williams V, White J (1991) Snake venom variability methods of study results and interpretation. Toxicon 29:1279–1303CrossRefPubMed
go back to reference Consroe P, Gerrish K, Egen N, Russel FE (1992) Intravenous dose lethality study of American pit viper venoms in mice using standardized methods. J Wilderness Med 3:162–167CrossRef Consroe P, Gerrish K, Egen N, Russel FE (1992) Intravenous dose lethality study of American pit viper venoms in mice using standardized methods. J Wilderness Med 3:162–167CrossRef
go back to reference da Silva WD, Tambourg DV (2011) The humoral immune reprise induced by snake venom toxins. Inflamm Allerg Drug Targets 10(5):343–357CrossRef da Silva WD, Tambourg DV (2011) The humoral immune reprise induced by snake venom toxins. Inflamm Allerg Drug Targets 10(5):343–357CrossRef
go back to reference De Almeda CN, da Silva CL, Couto HP, Escocard, Rade C, da Rocha DG, Sentinelli I (2008) Development of press to produce polyvalent IgG antibodies anti-African snake venom. Toxin 52:293–301 De Almeda CN, da Silva CL, Couto HP, Escocard, Rade C, da Rocha DG, Sentinelli I (2008) Development of press to produce polyvalent IgG antibodies anti-African snake venom. Toxin 52:293–301
go back to reference Duan HL, He Q-Y, Zhuu B, Wang WW, Li B, Zhang YZ, Deng Q-P, Zhang Y-F, Yu X-D (2016) Anti-Trimeresurus albolabris efficacy antibodies: preparation, purification and neutralization efficacy. J Venom Anim Toxins Incl Trop Dis 22(23):1–6 Duan HL, He Q-Y, Zhuu B, Wang WW, Li B, Zhang YZ, Deng Q-P, Zhang Y-F, Yu X-D (2016) Anti-Trimeresurus albolabris efficacy antibodies: preparation, purification and neutralization efficacy. J Venom Anim Toxins Incl Trop Dis 22(23):1–6
go back to reference Elaraby AK, El-Jakee J, Fahmy A, Kandid MM, Mahmood Z, Saida AA (2016) Lactoferrin: a novel strategy for antivenom therapy. Int J Pharmaceut Res Appl Sci 5(1):50–57 Elaraby AK, El-Jakee J, Fahmy A, Kandid MM, Mahmood Z, Saida AA (2016) Lactoferrin: a novel strategy for antivenom therapy. Int J Pharmaceut Res Appl Sci 5(1):50–57
go back to reference Forge MT, Cardoso JL, Castro SC, Ribeiro L, Franca FO, De Almeria ME, Kanuguti AS, Santo-Martins IS, Santoro ML, Mangeau JE, Warrell D, Theakston R (2014) A radomised blinded comparison of two doses of antivenom in the treatment of Bothrops envenoming in Sao Paulo, Brazil. Tran Roy Soc Trop Med Hyg 89:111–114 Forge MT, Cardoso JL, Castro SC, Ribeiro L, Franca FO, De Almeria ME, Kanuguti AS, Santo-Martins IS, Santoro ML, Mangeau JE, Warrell D, Theakston R (2014) A radomised blinded comparison of two doses of antivenom in the treatment of Bothrops envenoming in Sao Paulo, Brazil. Tran Roy Soc Trop Med Hyg 89:111–114
go back to reference Fry BG (2015) Venomous reptiles and their toxins: evolution, pathophysiology and biochemistry. Oxford University press, Oxford, p 546 Fry BG (2015) Venomous reptiles and their toxins: evolution, pathophysiology and biochemistry. Oxford University press, Oxford, p 546
go back to reference Fung HT, Yung WH, Crow P, Lam KW, Tan KS, Gironi A, Wong OF, Ades G, Kam CW, Tse ML (2012) Green viper antivenom from Thailand and Agkistrodon halys antivenin from chiria compared in treating Cryptelytoops albolabris envenomation of mice. Hong Kong Med J 18:40–45PubMed Fung HT, Yung WH, Crow P, Lam KW, Tan KS, Gironi A, Wong OF, Ades G, Kam CW, Tse ML (2012) Green viper antivenom from Thailand and Agkistrodon halys antivenin from chiria compared in treating Cryptelytoops albolabris envenomation of mice. Hong Kong Med J 18:40–45PubMed
go back to reference Glenn JJ, Straight RC (1978) Mojave rattlesnake (Crotalus scutulatus saitilatus) venom variation in toxicity with geographical origin. Toxicon 16:81–84CrossRefPubMed Glenn JJ, Straight RC (1978) Mojave rattlesnake (Crotalus scutulatus saitilatus) venom variation in toxicity with geographical origin. Toxicon 16:81–84CrossRefPubMed
go back to reference Gutierrez JM, Lomonte B, Leon G, Rucavado A, Chaves F (2007) Trends in snake bite envenomation therapy; scientific, technological and public health consideration. Curr Pharm Des 13:2935–2950CrossRefPubMed Gutierrez JM, Lomonte B, Leon G, Rucavado A, Chaves F (2007) Trends in snake bite envenomation therapy; scientific, technological and public health consideration. Curr Pharm Des 13:2935–2950CrossRefPubMed
go back to reference Isbister GK (2010) Antivenom efficacy or effectiveness. The Australian experience. Toxicology 268:148–154CrossRefPubMed Isbister GK (2010) Antivenom efficacy or effectiveness. The Australian experience. Toxicology 268:148–154CrossRefPubMed
go back to reference Isbister GK, Brown SG, MacDonald E, White J, Alcurine BJ (2008) Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis. Med J Aust 188:473–476PubMed Isbister GK, Brown SG, MacDonald E, White J, Alcurine BJ (2008) Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis. Med J Aust 188:473–476PubMed
go back to reference Jelinek GA, Tweed C, Lynch D, Celenza T, Bush B, Michalopoulos N (2004) Cross reactivity between venomous, mildly venomous, and non-venomous snake venoms with the Commonwealth serum laboratories venom detection kit. Emerg Med Australas 16(5-6):384–386 Jelinek GA, Tweed C, Lynch D, Celenza T, Bush B, Michalopoulos N (2004) Cross reactivity between venomous, mildly venomous, and non-venomous snake venoms with the Commonwealth serum laboratories venom detection kit. Emerg Med Australas 16(5-6):384–386
go back to reference Karam HM, Shaaban EA, Mohamed AF, Zaki HF, Kenawy SA (2015) New approach for improving production of Naja haja snake antirenom. IJSRP 5(3):1–11 Karam HM, Shaaban EA, Mohamed AF, Zaki HF, Kenawy SA (2015) New approach for improving production of Naja haja snake antirenom. IJSRP 5(3):1–11
go back to reference Khaddah FZ, Benaiji B, Djebari FL, Chgoury F, Boussadda L, Wadi A, Oukkache N, Ghalim N (2014) Assessment of preclinical efficacy antivenoms produced in rabbit by immunological methods and neutralization assays. J Chem Pharm Res 6(12):446–455 Khaddah FZ, Benaiji B, Djebari FL, Chgoury F, Boussadda L, Wadi A, Oukkache N, Ghalim N (2014) Assessment of preclinical efficacy antivenoms produced in rabbit by immunological methods and neutralization assays. J Chem Pharm Res 6(12):446–455
go back to reference Krishnan LK, Saroja JB, Rajalingam M, John V, Valappil MP, Sreelathal V (2015) Rabbit snake bite model to assess safety and efficacy of anti-viper chicken antibodies (IofG). AJCEM 3(1):32–38CrossRef Krishnan LK, Saroja JB, Rajalingam M, John V, Valappil MP, Sreelathal V (2015) Rabbit snake bite model to assess safety and efficacy of anti-viper chicken antibodies (IofG). AJCEM 3(1):32–38CrossRef
go back to reference Larsson A, Sjoquist J (1990) Chicken lgY utilizing evolutionary difference. Comp Immunol Microbial Infect Dis 13:199–201CrossRef Larsson A, Sjoquist J (1990) Chicken lgY utilizing evolutionary difference. Comp Immunol Microbial Infect Dis 13:199–201CrossRef
go back to reference Lipman NS, Trudel LJ, Murphy JC, Sahali Y (1992) Comparison of immune response potentiation and in vivo inflammatory effects of freund’s and RIBI adjuvans in mice. Lab Anim Sci 42(2):193–197PubMed Lipman NS, Trudel LJ, Murphy JC, Sahali Y (1992) Comparison of immune response potentiation and in vivo inflammatory effects of freund’s and RIBI adjuvans in mice. Lab Anim Sci 42(2):193–197PubMed
go back to reference Liu S, Dong W, Kong T (2010) Preparation and characterization of immunoglobulin yolk against the venom of Naja naja atra. Indian J Exp Biol 48(8):778–785 Liu S, Dong W, Kong T (2010) Preparation and characterization of immunoglobulin yolk against the venom of Naja naja atra. Indian J Exp Biol 48(8):778–785
go back to reference Maduwager K, Silva A, Oleavy MA, Hodgson WC, Isbister GK (2016) Efficacy of Indian polyvalent snake antivenoms against Sri Lankan snake venoms. Lethality studies or clinically focused in vitro studies. Sci Rep 6:1–11CrossRef Maduwager K, Silva A, Oleavy MA, Hodgson WC, Isbister GK (2016) Efficacy of Indian polyvalent snake antivenoms against Sri Lankan snake venoms. Lethality studies or clinically focused in vitro studies. Sci Rep 6:1–11CrossRef
go back to reference Mahan T, Venom P, Rav DN (2013) Norel adjuvants and delivery vehicles for vaccines development: a road ahead. Ind J Med Res 138(5):779–795 Mahan T, Venom P, Rav DN (2013) Norel adjuvants and delivery vehicles for vaccines development: a road ahead. Ind J Med Res 138(5):779–795
go back to reference Maija DC, Mary VB, Lal AV, Umashankar PR, Krishnan LK (2001) Improved method for isolation of anti-viper venom antibodies from chicken egg yolk. J Biochem Biophys Method 51:129 Maija DC, Mary VB, Lal AV, Umashankar PR, Krishnan LK (2001) Improved method for isolation of anti-viper venom antibodies from chicken egg yolk. J Biochem Biophys Method 51:129
go back to reference Meanatchisasudaram S, Parameswari G, Michael A (2009) Studies on antivenom activity of Andrographis paniculata and Aristolochia India plant extracts against Daboia russelli venom by in vivo and in vitro methods. Ind. J Sci Technol 2(4):76–79 Meanatchisasudaram S, Parameswari G, Michael A (2009) Studies on antivenom activity of Andrographis paniculata and Aristolochia India plant extracts against Daboia russelli venom by in vivo and in vitro methods. Ind. J Sci Technol 2(4):76–79
go back to reference Morokuma K, Kobori N, Fukuda T, Takashira M (2011) Experimental manufacture of equine antivenom against yamakagashi (Rabdophis tigrinus). Jpn J Infect Dis 64(5):397–402PubMed Morokuma K, Kobori N, Fukuda T, Takashira M (2011) Experimental manufacture of equine antivenom against yamakagashi (Rabdophis tigrinus). Jpn J Infect Dis 64(5):397–402PubMed
go back to reference Moussa IN, Hassan AM, Alesisa AM, Al Arfaj AA, Salem BMM, Alrejai SA (2012) Protective efficacy of immuniglobulins Y prepared against Cerastes cerastes snake venom in the kingdom of Saudi Arabia. Saudi Med J 33(8):846–851PubMed Moussa IN, Hassan AM, Alesisa AM, Al Arfaj AA, Salem BMM, Alrejai SA (2012) Protective efficacy of immuniglobulins Y prepared against Cerastes cerastes snake venom in the kingdom of Saudi Arabia. Saudi Med J 33(8):846–851PubMed
go back to reference Okkache N, El Jaoudi R, Ghalion N (2014) Evaluation of the lethal potency of scorpion and snake venoms and comparison between intraperitoneal and intravenous injection routes. Toxin 6:1873–1881CrossRef Okkache N, El Jaoudi R, Ghalion N (2014) Evaluation of the lethal potency of scorpion and snake venoms and comparison between intraperitoneal and intravenous injection routes. Toxin 6:1873–1881CrossRef
go back to reference Oliviera JCR, Montes de Oca H, Duarte MN, Diniz CR, Fortes-Dias CL (2002) Toxicity of South American snakes venoms measured by an invitro cell culture assay. Toxicon 40(3):321–325CrossRef Oliviera JCR, Montes de Oca H, Duarte MN, Diniz CR, Fortes-Dias CL (2002) Toxicity of South American snakes venoms measured by an invitro cell culture assay. Toxicon 40(3):321–325CrossRef
go back to reference Pakmanee N, Noiphrom J, Kay A, Pormuttakun D, Sakolparp L, Hemmale W, Akesowan S, Khomvilar S, Sitparija V (2013) Comparative abilities of phospholipase A2, and coagulant activities induced by Daboia sianensis venom and their antiinflammatory activity. Sci Asia 39:160–166CrossRef Pakmanee N, Noiphrom J, Kay A, Pormuttakun D, Sakolparp L, Hemmale W, Akesowan S, Khomvilar S, Sitparija V (2013) Comparative abilities of phospholipase A2, and coagulant activities induced by Daboia sianensis venom and their antiinflammatory activity. Sci Asia 39:160–166CrossRef
go back to reference Pawode BS, Sivi NC, Shaikh IK, Waghmare AB, Jalhar ND, Wagh VB, Pawode AS, Waykar IG, Polius-Lele M (2016) Rapid and selective detection of experimental snake envenomation-use of gold nanoparticte based literal flow assay. Toxicon 119(1):299–306CrossRef Pawode BS, Sivi NC, Shaikh IK, Waghmare AB, Jalhar ND, Wagh VB, Pawode AS, Waykar IG, Polius-Lele M (2016) Rapid and selective detection of experimental snake envenomation-use of gold nanoparticte based literal flow assay. Toxicon 119(1):299–306CrossRef
go back to reference Riviere G, Choumet V, Audebert F, Saboraud A, Debray M, Scherrmann JN, Bon C (1997) Effect of antivenom on venom pharmakinetics in experimentally envenomed rabbits towards an optimization of antivenom therapy. J Pharmacol Exp Ther 281(1):1PubMed Riviere G, Choumet V, Audebert F, Saboraud A, Debray M, Scherrmann JN, Bon C (1997) Effect of antivenom on venom pharmakinetics in experimentally envenomed rabbits towards an optimization of antivenom therapy. J Pharmacol Exp Ther 281(1):1PubMed
go back to reference Saganuwan S (2016) The new logarithm for calculation of median lethal dose (LD50) and effective dose fifty (ED50) for Micrarus fulvius venom and antivenom. Int J Vet Sci Med 3(2):1–4CrossRef Saganuwan S (2016) The new logarithm for calculation of median lethal dose (LD50) and effective dose fifty (ED50) for Micrarus fulvius venom and antivenom. Int J Vet Sci Med 3(2):1–4CrossRef
go back to reference Segura A, Herreva M, Vargars M (2012) Intra specific variation and cross neutralization by antivenom. Toxicon 59:158–162CrossRefPubMed Segura A, Herreva M, Vargars M (2012) Intra specific variation and cross neutralization by antivenom. Toxicon 59:158–162CrossRefPubMed
go back to reference Shaban EA, Hafez MN (2003) Ability of gamma-irradiated polyvalent antivenom to neutralize the toxicity of the Egyptian cobra (Naja haje) venom. Egypt J Hosp Med 13:1335–1152 Shaban EA, Hafez MN (2003) Ability of gamma-irradiated polyvalent antivenom to neutralize the toxicity of the Egyptian cobra (Naja haje) venom. Egypt J Hosp Med 13:1335–1152
go back to reference Silverstein D, Hopper K, (2008) Small animal critical care medicine, 2nd ed, Elsevier Health Science, Amsterdam, p 1000 Silverstein D, Hopper K, (2008) Small animal critical care medicine, 2nd ed, Elsevier Health Science, Amsterdam, p 1000
go back to reference Tan CH, Sim SM, Gnanathasan CA, Fung SY, Tan NG (2014) Pharmacokinetics of the Sri Lankan hump-nosed pit viper intramuscular injections of the venom into rabbits. Toxicon 79:37–44CrossRefPubMed Tan CH, Sim SM, Gnanathasan CA, Fung SY, Tan NG (2014) Pharmacokinetics of the Sri Lankan hump-nosed pit viper intramuscular injections of the venom into rabbits. Toxicon 79:37–44CrossRefPubMed
go back to reference Tan C, Tan NH, Tan KY, Kong KO (2015) Antivenom cross-neutralization of the venoms of Hydrophis schistosus and hydrophis curtis, two common sea snakes in Malaysian waters. Toxin 7:572–581CrossRef Tan C, Tan NH, Tan KY, Kong KO (2015) Antivenom cross-neutralization of the venoms of Hydrophis schistosus and hydrophis curtis, two common sea snakes in Malaysian waters. Toxin 7:572–581CrossRef
go back to reference WHO (1971). Requirements for snake antivenous: requirements for biological substances, No 21. WHO Technical Report Section 463: 27–44 WHO (1971). Requirements for snake antivenous: requirements for biological substances, No 21. WHO Technical Report Section 463: 27–44
go back to reference Yeung JM, Little M, Murray LM, Jelinek GA, Daly FFS (2004) Antivenom dosing in 35 patients with severe brown snake (Pseudonaja) envenoming in Westerrn Australia over 10 years. Med J Aust 181:703–705PubMed Yeung JM, Little M, Murray LM, Jelinek GA, Daly FFS (2004) Antivenom dosing in 35 patients with severe brown snake (Pseudonaja) envenoming in Westerrn Australia over 10 years. Med J Aust 181:703–705PubMed
Metadata
Title
Calculation of effective dose fifty (ED50) of antivenom for American pit viper envenomation
Author
Saganuwan Alhaji Saganuwan
Publication date
01-09-2018
Publisher
Springer London
Published in
Comparative Clinical Pathology / Issue 5/2018
Print ISSN: 1618-5641
Electronic ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-018-2742-1

Other articles of this Issue 5/2018

Comparative Clinical Pathology 5/2018 Go to the issue